Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 50%High 1 · 50%

All‐cause non‐fatal serious adverse events ‐ children · patients with chronic asthma

Regular salmeterol showed no clear difference in all‐cause non‐fatal serious adverse events ‐ children compared with placebo (moderate certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 1.3 [0.82, 2.05]
5 studies · 1333 participants
Moderate

All‐cause non‐fatal serious adverse events ‐ adults and adolescents · patients with chronic asthma

Regular salmeterol leads to higher all‐cause non‐fatal serious adverse events ‐ adults and adolescents compared with placebo (high certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 1.14 [1.01, 1.28]
13 studies · 30196 participants
High